Valente Manuela 4

What Happened
Manuela Valente, Chief People Officer of SOPHiA GENETICS (SOPH), sold 3,824 shares in an open-market transaction on April 8, 2026. The weighted-average sale price was $4.85 per share (range $4.78–$4.94), for total proceeds of approximately $18,543. This was a sale (not a purchase) and was executed to satisfy tax withholding obligations related to RSU vesting.

Key Details

• Transaction date: April 8, 2026; Form filed April 10, 2026 (appears timely).
• Shares sold: 3,824; weighted-average price reported: $4.85; price range: $4.78–$4.94.
• Total proceeds: ~$18,543.
• Reason/footnotes: Sales effected to satisfy tax withholding for restricted stock units that vested on April 2 and 3, 2026; executed pursuant to a pre-established Rule 10b5-1 trading plan (non-discretionary).
• Footnote also notes the filer can provide breakdown of how many shares sold at each price within the stated range upon written request.
• Shares owned after the transaction: not reported in this filing.

Context
These transactions were tax-withholding related and part of a pre-established 10b5-1 plan, which insiders commonly use to sell shares tied to compensation events; such sales are generally considered routine and do not necessarily indicate a change in the insider’s view of the company. Purchases (not present here) tend to carry more informational weight for investors.